DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,305 | -12.1% | 70,571 | +10.4% | 0.00% | 0.0% |
| Q2 2023 | $719,010 | +121766.1% | 63,912 | +24.9% | 0.00% | 0.0% |
| Q1 2023 | $590 | +3.5% | 51,180 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $570 | -99.9% | 49,214 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $620,000 | +103.3% | 48,818 | +10.0% | 0.00% | – |
| Q2 2022 | $305,000 | -15.5% | 44,382 | +18.5% | 0.00% | – |
| Q1 2022 | $361,000 | -20.3% | 37,444 | -1.7% | 0.00% | -100.0% |
| Q4 2021 | $453,000 | -27.3% | 38,105 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $623,000 | -19.9% | 38,390 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $778,000 | +334.6% | 36,990 | +220.3% | 0.00% | – |
| Q1 2021 | $179,000 | – | 11,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |